EUVIMEDEUVIMED entdecken
Übersichtsarbeit

SREBPs in Metabolic Reprogramming and Disease: Mechanisms and Therapeutic Potential

Xinhong Zou, Yingyu Li iD, Mu Yang, Lei Liu, Rui Wu, Guoli Cui iD, Junfei Dai

The FASEB Journal · 30.06.2026 · 40 (12)

DOI: 10.1096/fj.202600280rr ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 12.06.2026. Verfasst von Xinhong Zou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medicine Department, Jiamusi University, Jiamusi, Heilongjiang Province, China. Hauptthemen laut MEDLINE: Sterol Regulatory Element Binding Proteins, Lipid Metabolism. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 156 Literaturangaben. Gefördert von: Heilongjiang Provincial Natural Science Foundation of China, "East Pole" Research Team of Jiamusi University, the Oral Biomedical Materials R&D and Personalized Manufacturing Characteristic Discipline Project of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sterol regulatory element‐binding proteins (SREBPs) are key transcription factors belonging to the basic helix–loop–helix leucine zipper (bHLH‐Zip) family. They play central roles in coordinating cellular lipid metabolic signaling and maintaining metabolic homeostasis. This review systematically summarizes the origin, classification, structural characteristics, and activation mechanisms of SREBPs mediated by the INSIG–SCAP–SREBP complex. Building on this, we further outline the lipid metabolic programs regulated by SREBPs, with a focus on their roles in de novo lipogenesis, triglyceride accumulation, cholesterol metabolism, and membrane remodeling. In addition, we provide a cross‐disease overview of SREBP‐driven metabolic reprogramming, highlighting its involvement in inflammation amplification, immune metabolic imbalance, disruption of cellular homeostasis, and malignant progression. Based on current advances, we also summarize emerging small‐molecule modulators targeting SREBP signaling and their potential therapeutic value. Furthermore, we discuss key challenges in current research, including functional heterogeneity, context‐dependent regulation, organismal and cell‐type specificity, as well as barriers to clinical translation. Overall, SREBPs are not only central regulators of lipid metabolism but also pivotal hubs linking metabolic remodeling to disease progression. A deeper understanding of their mechanisms and targeted interventions is expected to provide new insights for therapeutic strategies against metabolic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sterol Regulatory Element Binding ProteinsLipid MetabolismHumansMetabolic ReprogrammingAnimalsSignal TransductionLipogenesis

Stichwörter der Autor:innen

SREBPscholesterol homeostasisde novo lipogenesislipid metabolismmetabolic reprogrammingtherapeutic targets

Substanzen

Sterol Regulatory Element Binding Proteins

Autor:innen und Institutionen

  • Clinical Medicine Department, Jiamusi University, Jiamusi, Heilongjiang Province, China.
  • Basic Medical College of Jiamusi University, Jiamusi University, Jiamusi, Heilongjiang Province, China.
  • Laboratory Medicine, The First Affiliated Hospital of Jiamusi University, Jiamusi University, Jiamusi, Heilongjiang Province, China.

ORCID-Profile: Yingyu Li, Guoli Cui

Förderung

  • Heilongjiang Provincial Natural Science Foundation of China
  • "East Pole" Research Team of Jiamusi University
  • the Oral Biomedical Materials R&D and Personalized Manufacturing Characteristic Discipline Project of Heilongjiang Province

Zitieren

APA

Zou, X., Li, Y., Yang, M., Liu, L., Wu, R., Cui, G., & Dai, J. (2026). SREBPs in Metabolic Reprogramming and Disease: Mechanisms and Therapeutic Potential. The FASEB Journal, 40(12). https://doi.org/10.1096/fj.202600280rr

Vancouver

Zou X, Li Y, Yang M, Liu L, Wu R, Cui G, et al. SREBPs in Metabolic Reprogramming and Disease: Mechanisms and Therapeutic Potential. The FASEB Journal. 2026;40(12). doi:10.1096/fj.202600280rr

BibTeX
@article{Zou2026,
  author = {Zou, Xinhong and Li, Yingyu and Yang, Mu and Liu, Lei and Wu, Rui and Cui, Guoli and Dai, Junfei},
  title = {SREBPs in Metabolic Reprogramming and Disease: Mechanisms and Therapeutic Potential},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {12},
  doi = {10.1096/fj.202600280rr}
}
Kostenlos starten →